Étienne De Braekeleer

ÉD

Statistics

Publications

Citations

5.7K

H-Index

Active since

2009

Affiliations

Wellcome Sanger Institute(Current)

Wellcome/MRC Cambridge Stem Cell Institute

University of Cambridge

The Gurdon Institute

Cambridge University Hospitals NHS Foundation Trust

Étienne De Braekeleer is an author at Wellcome Sanger Institute specializing in molecular oncology, acute myeloid leukemia biology, and life sciences.

ORCID

Publications per year

2009–2021

Publications

Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia

Eliza Yankova, Wesley Blackaby, Mark R. Albertella et al. · Nature · 2021 · 1.3K citations · Full text

Medicine, Oncology, Pharmacology +13

Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control

Isaia Barbieri, Konstantinos Tzelepis, Luca Pandolfini et al. · Nature · 2017 · 1.1K citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +13

A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia

Konstantinos Tzelepis, Hiroko Koike-Yusa, Étienne De Braekeleer et al. · Cell Reports · 2016 · 834 citations · Full text

Life Sciences, Genetics, Molecular Biology +14

The MLL recombinome of acute leukemias in 2013

Claus Meyer, Jörg Hofmann, Thomas Burmeister et al. · Leukemia · 2013 · 507 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy

Joanne I. Hsu, Tajhal Dayaram, Ayala Tovy et al. · Cell stem cell · 2018 · 425 citations · Full text

Medicine, Hematology, Oncology +17

1–5 of 18